Viewing Study NCT00108368



Ignite Creation Date: 2024-05-05 @ 11:40 AM
Last Modification Date: 2024-10-26 @ 9:11 AM
Study NCT ID: NCT00108368
Status: COMPLETED
Last Update Posted: 2009-01-21
First Post: 2005-04-14

Brief Title: The Effects of Risperidone and Olanzapine on Thinking
Sponsor: US Department of Veterans Affairs
Organization: VA Office of Research and Development

Study Overview

Official Title: The Cognitive Effects of Risperidone and Olanzapine
Status: COMPLETED
Status Verified Date: 2007-09
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: None
Brief Summary: The goal of this research is to find ways to maximize the benefits of antipsychotic medications for cognition

Hypothesis Risperidone and olanzapine will show greater benefits than conventional medications on assessments of social cognition particularly affect perception and social perception
Detailed Description: None

Study Oversight

Has Oversight DMC: None
Is a FDA Regulated Drug?: None
Is a FDA Regulated Device?: None
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: None